| Acetazolamide in acute decompensated heart failure with volume overload W Mullens, J Dauw, P Martens, FH Verbrugge, P Nijst, E Meekers, ... New England Journal of Medicine 387 (13), 1185-1195, 2022 | 391 | 2022 |
| Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction P Martens, P Nijst, FH Verbrugge, K Smeets, M Dupont, W Mullens Acta Cardiologica 73 (2), 115-123, 2018 | 201 | 2018 |
| Hyponatremia in acute decompensated heart failure: depletion versus dilution FH Verbrugge, P Steels, L Grieten, P Nijst, WHW Tang, W Mullens Journal of the American College of Cardiology 65 (5), 480-492, 2015 | 193 | 2015 |
| Renal sodium avidity in heart failure: from pathophysiology to treatment strategies W Mullens, FH Verbrugge, P Nijst, WHW Tang European heart journal 38 (24), 1872-1882, 2017 | 191 | 2017 |
| The pathophysiological role of interstitial sodium in heart failure P Nijst, FH Verbrugge, L Grieten, M Dupont, P Steels, WHW Tang, ... Journal of the American College of Cardiology 65 (4), 378-388, 2015 | 191 | 2015 |
| Intrarenal flow alterations during transition from euvolemia to intravascular volume expansion in heart failure patients P Nijst, P Martens, M Dupont, WHW Tang, W Mullens JACC: Heart Failure 5 (9), 672-681, 2017 | 156 | 2017 |
| Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial W Mullens, FH Verbrugge, P Nijst, P Martens, K Tartaglia, E Theunissen, ... European journal of heart failure 20 (11), 1591-1600, 2018 | 111 | 2018 |
| Endothelial glycocalyx as biomarker for cardiovascular diseases: mechanistic and clinical implications YH Kim, P Nijst, K Kiefer, WHW Tang Current heart failure reports 14, 117-126, 2017 | 100 | 2017 |
| Urinary composition during decongestive treatment in heart failure with reduced ejection fraction FH Verbrugge, P Nijst, M Dupont, J Penders, WHW Tang, W Mullens Circulation: Heart Failure 7 (5), 766-772, 2014 | 100 | 2014 |
| Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload F H. Verbrugge, M Dupont, P B. Bertrand, P Nijst, J Penders, J Dens, ... Acta Cardiologica 70 (3), 265-273, 2015 | 96 | 2015 |
| The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy—the IRON-CRT trial P Martens, M Dupont, J Dauw, P Nijst, L Herbots, P Dendale, ... European heart journal 42 (48), 4905-4914, 2021 | 90 | 2021 |
| Current approach to decongestive therapy in acute heart failure P Martens, P Nijst, W Mullens Current heart failure reports 12, 367-378, 2015 | 86 | 2015 |
| Urinary sodium profiling in chronic heart failure to detect development of acute decompensated heart failure P Martens, M Dupont, FH Verbrugge, K Damman, N Degryse, P Nijst, ... JACC: Heart Failure 7 (5), 404-414, 2019 | 65 | 2019 |
| Impact of iron deficiency on response to and remodeling after cardiac resynchronization therapy P Martens, F Verbrugge, P Nijst, M Dupont, WHW Tang, W Mullens The American Journal of Cardiology 119 (1), 65-70, 2017 | 59 | 2017 |
| Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: insights from TOPCAT JL Grodin, S Philips, W Mullens, P Nijst, P Martens, JC Fang, MH Drazner, ... European journal of heart failure 21 (5), 634-642, 2019 | 57 | 2019 |
| Cardiac output and renal dysfunction: definitely more than impaired flow W Mullens, P Nijst Journal of the American College of Cardiology 67 (19), 2209-2212, 2016 | 48 | 2016 |
| Heart failure with myocardial recovery-the patient whose heart failure has improved: what next? P Nijst, P Martens, W Mullens Progress in cardiovascular diseases 60 (2), 226-236, 2017 | 40 | 2017 |
| The effect of decongestion on intrarenal venous flow patterns in patients with acute heart failure JM Ter Maaten, J Dauw, P Martens, F Somers, K Damman, C Metalidis, ... Journal of Cardiac Failure 27 (1), 29-34, 2021 | 39 | 2021 |
| Acetazolamide in decompensated heart failure with volume overload trial (ADVOR): baseline characteristics W Mullens, J Dauw, P Martens, E Meekers, P Nijst, FH Verbrugge, ... European journal of heart failure 24 (9), 1601-1610, 2022 | 36 | 2022 |
| Renal function and decongestion with acetazolamide in acute decompensated heart failure: the ADVOR trial E Meekers, J Dauw, P Martens, S Dhont, FH Verbrugge, P Nijst, ... European Heart Journal 44 (37), 3672-3682, 2023 | 35 | 2023 |
